TP53 and B-cell chronic lymphocytic leukemia: In addition, a recent paper from the German CLL Study Group found an association between short telomere length, TP53 abnormalities, early relapse after chemoimmunotherapy and adverse survival.33 In particular, cases with 17p- or TP53 mutations had the shortest telomeres length, increase genomic complexity as well as clonal evolution.33